BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11483731)

  • 1. Copper binding to the PrP isoforms: a putative marker of their conformation and function.
    Shaked Y; Rosenmann H; Hijazi N; Halimi M; Gabizon R
    J Virol; 2001 Sep; 75(17):7872-4. PubMed ID: 11483731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonication induced intermediate in prion protein conversion.
    Zukas AA; Bruederle CE; Carter JM
    Protein Pept Lett; 2008; 15(2):206-11. PubMed ID: 18289112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding.
    Li L; Guest W; Huang A; Plotkin SS; Cashman NR
    Protein Eng Des Sel; 2009 Aug; 22(8):523-9. PubMed ID: 19602568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisit the effect of fibrillization on functions of prion protein from the perspective of Cu(II) binding.
    Qi X; McGuirl M
    Biochem Biophys Res Commun; 2018 Sep; 503(1):32-37. PubMed ID: 29807014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypothesis of the catalytic action of nucleic acid on the conversion of prion protein.
    Cordeiro Y; Silva JL
    Protein Pept Lett; 2005 Apr; 12(3):251-5. PubMed ID: 15777274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
    Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific prion-protein conformation determined by metal ions.
    Wadsworth JD; Hill AF; Joiner S; Jackson GS; Clarke AR; Collinge J
    Nat Cell Biol; 1999 May; 1(1):55-9. PubMed ID: 10559865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions and conversions of prion protein isoforms.
    Caughey B; Raymond GJ; Callahan MA; Wong C; Baron GS; Xiong LW
    Adv Protein Chem; 2001; 57():139-69. PubMed ID: 11447689
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).
    Müller H; Strom A; Hunsmann G; Stuke AW
    Biochem J; 2005 May; 388(Pt 1):371-8. PubMed ID: 15658935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
    Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
    PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
    Zou WQ; Cashman NR
    J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
    Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
    Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the antigenicity of copper-treated cellular prion protein with the scrapie isoform.
    Wong BS; Li R; Sassoon J; Kang SC; Liu T; Pan T; Greenspan NS; Wisniewski T; Brown DR; Sy MS
    Cell Mol Life Sci; 2003 Jun; 60(6):1224-34. PubMed ID: 12861388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.